Pfizer beats 3Q expectations, raises 2015 earnings forecast
NEW YORK (AP) — Pfizer topped analyst expectations for the third quarter and raised its 2015 earnings forecast again, as sales growth from several products helped the world's second-largest drugmaker counter costs tied to a $17-billion acquisition and pressure from foreign exchange rates.
Read more »